This trial is testing a new drug, KT-474, for safety, tolerability, and how well it works in patients with atopic dermatitis or hidradenitis suppurativa. They will also study how food affects the absorption of the drug in healthy volunteers.
KT-474 is a medication that is used to treat Hidradenitis Suppurativa, a condition that causes small, painful bumps under the skin. KT-474 was previously approved by the FDA to treat a different condition, but it is now being used to treat Hidradenitis Suppurativa. This treatment is free.